Effect of Nintedanib on Decline in Forced Vital Capacity (FVC) in Patients with Progressive Fibrosing Interstitial Lung Diseases (ILDs) by Time Since Diagnosis

Autor:	D Skowasch, M Strek, R W Hallowell, J Kus, H Nunes, T Suda, S Tomassetti, H Mueller, K B Rohr, K R Flaherty
Rok vydání:	2021
Zdroj:	TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD.
DOI:	10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1907
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0696674c2cca0ad59e0a397ee25adb40 https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1907 Zobrazit plný text záznamu